Orbusneich
Clinical trials sponsored by Orbusneich, explained in plain language.
-
Heart stent under the microscope in 3-Year safety watch
Disease control OngoingThis study is collecting real-world safety and performance data on a specific drug-coated stent used to open blocked heart arteries. It will follow 251 patients who receive the stent as part of their regular care for up to three years after their procedure. The goal is to monitor…
Sponsor: OrbusNeich • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New balloon treatment for clogged heart arteries under Long-Term watch
Disease control OngoingThis study is collecting real-world safety and performance data on a special drug-coated balloon used to treat blocked heart arteries. Doctors are following 282 patients in Europe for three years after their procedure to see how well the treatment works over time and monitor for …
Sponsor: OrbusNeich • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC